Detecting Absence Seizures Using Eye Tracking

Status Completed

Clinical Trial Summary

The goal of this study is to develop a comfortable system that uses a wearable eye-tracker similar to eyeglasses to assist people with epilepsy in counting and measuring the severity of seizures. Participants will wear an eye-tracker during a routine EEG.

Clinical Trial Description

Seizures can be difficult to detect outside of the hospital even with careful observation by a caregiver. EEG is the best method that we have to detect seizures- but it is uncomfortable for long term use outside of the hospital. The goal of this study is to develop a comfortable system that uses a wearable eye-tracker similar to eyeglasses to assist people with epilepsy in counting and measuring the severity of seizures. People participating in this study will have a routine EEG performed while an eye tracker measures eye movements. After the EEG is complete the researchers will compare the eye movements to the EEG to develop a software program that can detect seizures from eye movements. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04439656
Study type	Observational
Source	Eysz, Inc.
Contact
Status	Completed
Phase
Start date	July 15, 2020
Completion date	June 28, 2022

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT02850913` - Doxycycline for the Treatment of Nodding Syndrome	Phase 2
Recruiting	`NCT04076449` - Quantitative Susceptibility Biomarker and Brain Structural Property for Cerebral Cavernous Malformation Related Epilepsy
Not yet recruiting	`NCT06045676` - Electrocardiographic Changes Among Epileptic and Non Epileptic Seizures in Children at Sohag University Hospital
Completed	`NCT03722212` - Early Diagnosis of the GLUT1 Deficiency Syndrome With a Blood Based Test	N/A
Not yet recruiting	`NCT05649891` - Checklists Resuscitation Emergency Department	N/A
Completed	`NCT02897856` - Efficacy and Safety of Intramuscular Midazolam Compared to Buccal Midazolam in Pediatric Seizures	Phase 4
Completed	`NCT01239212` - Dosing of Levetiracetam (Keppra) in Neonates	Phase 1/Phase 2
Completed	`NCT01236001` - Belgian Drug-utilization Study to Evaluate the Use of VIMPAT® as Adjunctive Treatment of Partial Onset Seizures in Subjects Aged 16 and Older	N/A
Completed	`NCT01703468` - Crossover Bioequivalence Study of Oxcarbazepine 600 mg Suspension Under Fed Conditions	Phase 1
Completed	`NCT01702623` - Crossover Bioequivalence Study of Oxcarbazepine 600 mg Suspension Under Fasted Conditions	Phase 1
Recruiting	`NCT02216500` - Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy	N/A
Completed	`NCT00236717` - A Study of the Effectiveness and Safety of Topiramate Compared With a Standard Therapy in Patients Newly Diagnosed With Epilepsy	Phase 3
Terminated	`NCT03954314` - DEPOSITION - Decreasing Postoperative Blood Loss by Topical vs. Intravenous Tranexamic Acid in Open Cardiac Surgery	Phase 3
Completed	`NCT05103735` - Propofol-remifentanyl Versus Dexmedetomidine in Awake Craniotomy: Impact on Electroclinical Seizure Activity
Terminated	`NCT03790436` - Betaquik as an Adjunct to Dietary Management of Epilepsy in Adults on the Modified Atkins Diet	N/A
Completed	`NCT06451289` - Study on Optic Nerve Sheath Diameter Measurements in Prolonged Pediatric Seizures
Recruiting	`NCT02552511` - Epidemiology Study on Neonatal Seizure
Recruiting	`NCT05339126` - RNS System LGS Feasibility Study	Phase 2
Active, not recruiting	`NCT04595786` - The Safety of Intravenous Tranexamic Acid in Patients Undergoing Supratentorial Meningiomas Resection	N/A
Recruiting	`NCT04770337` - Pivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal Epilepsy	N/A